Pharmacokinetics of risperidone in different application forms – Comparing long-acting injectable and oral formulations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of risperidone in different application forms – Comparing long-acting injectable and oral formulations

Published:2018-01 Issue:1 Volume:28 Page:130-137
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Schoretsanitis Georgios,de Leon Jose,Haen Ekkehard,Stegmann Benedikt,Hiemke Christoph,Gründer Gerhard,Paulzen Michael

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference45 articles.

1. Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics;Alphs;Neuropsychiatr. Dis. Treat.,2013

2. Determination of five commonly used antipsychotics in human serum by high performance-liquid chromatography (HPLC) and electrochemical detection;Bader;Pharmacopsychiatry,2005

3. Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study;Bai;J. Clin. Psychiatry,2007

4. Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors;Balant-Gorgia;Ther. drug Monit.,1999

5. Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service;Castberg;Ther. drug Monit.,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis;Pharmacopsychiatry;2024-02-22

3. Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations;Expert Opinion on Drug Metabolism & Toxicology;2023-04-03

4. Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review;Advances in Therapy;2022-09-01

5. Mood Stabilizers: Course and Duration of Therapy, Withdrawal Syndromes, and Resistance to Therapy;NeuroPsychopharmacotherapy;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3